Company: CMND
Filing Date: 2025-11-19
Form Type: 6-K
Source: 0001213900-25-112331
Chunk: 1

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-19
Form: 6-K
Chunk 1
---
-K (this “Report”) shall not constitute an offer to sell or the solicitation
to buy, nor shall there be any sale of, any of the securities described herein in any state or jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

A copy of the Securities Purchase Agreement is filed as Exhibit 10.1
to this Report and is incorporated by reference herein. The foregoing summary of such document is subject to, and qualified in its
entirety by reference to, such exhibit.

A copy of the opinion of Daniel N. Bloch relating to the securities
issued in the Offering is attached as Exhibit 5.1.

This Report, is
incorporated by reference into the Company’s Registration Statements on Form F-3 (File Nos. 333-275991, 333-270859, 333-273293)
and Form S-8 (File No. 333-283695),
filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the
extent not superseded by documents or reports subsequently filed or furnished.

Forward Looking Statements

This Report of on Form 6-K contains statements which constitute forward
looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward
looking statements are based upon the Company’s present intent, beliefs or expectations, but forward looking statements are not
guaranteed to occur and may not occur for various reasons, including some reasons which are beyond the Company’s control. For example,
this Report states that the Offering is expected to close on or about November 20, 2025. In fact, the closing of the Offering is subject
to various conditions and contingencies as are customary in securities purchase agreements in the United States. If these conditions
are not satisfied or the specified contingencies do not occur, this Offering may not close. For this reason, among others, you should
not place undue reliance upon the Company’s forward looking statements. Except as required by law, the Company undertakes no obligation
to revise or update any forward looking statements in order to reflect any event or circumstance that may arise after the date of this
Report on Form 6-K.

<div align='center'>1

EXHIBIT INDEX</div>

| Exhibit No. |     |                                                             |
| 5.1         |     | Opinion